학술논문

HIV, HIV-specific Factors and Myocardial Disease in Women
Document Type
article
Source
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Immunology
HIV/AIDS
Clinical Research
Infectious Diseases
Heart Disease
Prevention
Cardiovascular
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Infection
Good Health and Well Being
HIV
Women's Interagency HIV Study
antiretroviral therapy
cardiac magnetic resonance
myocardial fibro-inflammation
Biological Sciences
Medical and Health Sciences
Microbiology
Clinical sciences
Language
Abstract
BackgroundPeople with HIV (PWH) have an increased risk of cardiovascular disease (CVD). Cardiac magnetic resonance (CMR) has documented higher myocardial fibrosis, inflammation and steatosis in PWH, but studies have mostly relied on healthy volunteers as comparators and focused on men.MethodsWe investigated the associations of HIV and HIV-specific factors with CMR phenotypes in female participants enrolled in the Women's Interagency HIV Study's New York and San Francisco sites. Primary phenotypes included myocardial native (n) T1 (fibro-inflammation), extracellular volume fraction (ECV, fibrosis) and triglyceride content (steatosis). Associations were evaluated with multivariable linear regression, and results pooled or meta-analyzed across centers.ResultsAmong 261 women with HIV (WWH, total n = 362), 76.2% had undetectable viremia at CMR. For the 82.8% receiving continuous antiretroviral therapy (ART) in the preceding 5 years, adherence was 51.7%, and 71.3% failed to achieve persistent viral suppression (42.2% with peak viral load